| t-PA | tissue plasminogen activator |
|---|
| tPA | tissue Plasminogen Activator |
|---|---|
| rh-tPA | recombinant tissue plasminogen activator |
| TPA | tannic acid, polyphosphomolybdic acid, and amino acid; 12-0-tetradecanoyl-phorbol-13-acetate; third-... |
| t-PA | tissue PA |
|---|---|
| t-PA Ag | Tissue plasminogen activator antigen |
| t-PA:Ag | Tissue-type plasminogen activator antigen |
| TPA | 1,2-tetradecanoyl-phorbol-13-acetate |
|---|---|
| TPA | 12-0-Tetradecanoyl-13-Phorbol-Acetate |
| TPA | 4beta-12-O-tetradecanoylphorbol 13-acetate |
| GUSTO-I | Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries |
| r-tPA | Recombinant Tissue-Type Plasminogen Activator |
| tpa | Tissue plasminogen activator or TPA is thrombolytic agent used to dissolve blood clots. TPA is introduced into a vein (intravenous) or directly into a blocked artery. Because TPA is produced using recombinant DNA technology, it tends to be more expensive than urokinase or streptokinase. (27 Sep 1997) |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|